Healthcare Stocks: NeoGenomics Faces Debt, iRhythm & UnitedHealth Thrive

Healthcare stocks have been struggling, but two stand out: iRhythm Technologies and UnitedHealth Group. iRhythm, with a $3.94 billion market cap, has seen revenue jump 23.1% yearly over two years and is finally cash flow positive. Trading at $125 per share, its a solid player. UnitedHealth Group, with a $321.1 billion market cap, has grown revenue 11.3% annually over five years and offers top returns on capital. At $352.76 per share, its a giant in the sector. However, NeoGenomics, with a $1.06 billion market cap, is struggling with negative returns on capital and a high debt load, making it a risky investment. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4469439b2a712e19